Kyverna Therapeutics, Inc.
KYTX
$8.17
$0.091.11%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 199.43M | 236.45M | 279.25M | 171.14M | 211.68M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.02M | 5.18M | 7.30M | 3.79M | 2.65M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 100.00K | 100.00K | 100.00K | -- | -- |
| Total Current Assets | 206.54M | 241.73M | 282.95M | 174.93M | 214.33M |
|
|
|||||
| Total Current Assets | 206.54M | 241.73M | 282.95M | 174.93M | 214.33M |
| Net Property, Plant & Equipment | 9.29M | 9.73M | 5.42M | 6.32M | 7.58M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.00M | 5.57M | 5.45M | 5.91M | 4.60M |
| Total Assets | 219.82M | 257.02M | 293.83M | 187.16M | 226.51M |
|
|
|||||
| Total Accounts Payable | 2.93M | 11.60M | 5.31M | 3.02M | 9.92M |
| Total Accrued Expenses | 18.34M | 16.09M | 27.21M | 27.17M | 26.30M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.53M | 1.99M | 3.97M | 3.69M | 3.58M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 22.80M | 29.67M | 36.49M | 33.87M | 39.79M |
|
|
|||||
| Total Current Liabilities | 22.80M | 29.67M | 36.49M | 33.87M | 39.79M |
| Long-Term Debt | 24.88M | 24.81M | 24.74M | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.59M | 6.96M | 320.00K | 1.34M | 2.34M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 54.27M | 61.44M | 61.55M | 35.21M | 42.13M |
|
|
|||||
| Common Stock & APIC | 668.57M | 660.23M | 657.01M | 538.94M | 534.63M |
| Retained Earnings | -502.87M | -464.56M | -424.83M | -387.02M | -350.24M |
| Treasury Stock & Other | -142.00K | -96.00K | 97.00K | 29.00K | -20.00K |
| Total Common Equity | 165.55M | 195.58M | 232.28M | 151.95M | 184.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 165.55M | 195.58M | 232.28M | 151.95M | 184.38M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 165.55M | 195.58M | 232.28M | 151.95M | 184.38M |
|
|
|||||